Search results for "marker"

showing 10 items of 3799 documents

Annexin-1 downregulation in thyroid cancer correlates to the degree of tumour differentiation

2006

We investigated the expression of annexin-1 (ANXA1) in thyroid carcinoma cell lines and in thyroid cancers with a different degree of differentiation. The highest level of ANXA1 expression examined by Western blotting was detected in the papillary carcinoma cells (NPA) and in the follicular cells (WRO). On the other hand, the most undifferentiated thyroid carcinoma cells (ARO and FRO) presented the lowest level of ANXA1 expression. In surgical tissue specimens from 32 patients with thyroid cancers, we found high immunoreactivity for ANXA1 in papillary (PTC) and follicular (FTC) thyroid cancers while in undifferentiated thyroid cancers (UTC) the expression of the protein was barely detectabl…

endocrine systemCancer ResearchPathologymedicine.medical_specialtyannexin-1endocrine system diseasesCellular differentiationThyroid Glandmedicine.disease_causeThyroid carcinomaDownregulation and upregulationannexinopathieTumor Cells CulturedmedicineHumansThyroid Neoplasmsdifferentiation markerThyroid cancerThyroid NeoplasmAnnexin A1PharmacologyRegulation of gene expressionbusiness.industryThyroidCell Differentiationmedicine.diseaseapoptosithyroid carcinomaGene Expression Regulation Neoplasticmedicine.anatomical_structureOncologyCell cultureMolecular MedicineCarcinogenesisbusinessHumanCancer Biology & Therapy
researchProduct

Role of quercetin on sterigmatocystin-induced oxidative stress-mediated toxicity.

2021

Oxidative stress appears to be a common trigger for many of the effects associated with the exposure to various mycotoxins, including sterigmatocystin (STE). However, studies to alleviate STE toxicity through the use of natural antioxidants are sparsely reported in literature. In the present study, the cytoprotective effect of quercetin (QUE) was tested in SH-SY5Y cells against STE-induced oxidative stress and cytotoxicity. The MTT assay revealed that STE decreased cell viability, whereas pre-treatment of cells with QUE restored it. The QUE was also found to counteract STE-induced ROS generation and decrease STE-induced up-regulation of the expression of the stress-inducible enzymes HO-1 an…

endocrine systemCell SurvivalSterigmatocystinInflammationPharmacologyToxicologymedicine.disease_causeAntioxidantsImmunomodulationchemistry.chemical_compoundCell Line TumormedicineHumansMTT assayViability assayCytotoxicityInflammationChemistryNF-kappa BNF-κBGeneral MedicineOxidative StressGene Expression RegulationToxicityQuercetinmedicine.symptomOxidative stressBiomarkersFood ScienceSterigmatocystinFood and chemical toxicology : an international journal published for the British Industrial Biological Research Association
researchProduct

Somatostatin and Somatostatin Receptors: From Signaling to Clinical Applications in Neuroendocrine Neoplasms

2021

Neuroendocrine neoplasms (NENs) are heterogeneous neoplasms which arise from neuroendocrine cells that are distributed widely throughout the body. Although heterogenous, many of them share their ability to overexpress somatostatin receptors (SSTR) on their cell surface. Due to this, SSTR and somatostatin have been a large subject of interest in the discovery of potential biomarkers and treatment options for the disease. The aim of this review is to describe the molecular characteristics of somatostatin and somatostatin receptors and its application in diagnosis and therapy on patients with NENs as well as the use in the near future of somatostatin antagonists.

endocrine systemQH301-705.5CellMedicine (miscellaneous)ReviewGeneral Biochemistry Genetics and Molecular BiologymedicineBiology (General)Tumorspeptide receptor radionuclide therapyReceptors d'hormonesneuroendocrine neoplasmssomatostatin analoguesSomatostatin receptorbusiness.industryTreatment optionsLU-DOTA-TATEmedicine.anatomical_structureSomatostatinPotential biomarkerssomatostatin receptorssomatostatin antagonistsCancer research68Ga PETbusinesshormones hormone substitutes and hormone antagonistsBiomedicines
researchProduct

EZH2 mutations are frequent and represent an early event in follicular lymphoma

2013

Gain of function mutations in the H3K27 methyltransferase EZH2 represent a promising therapeutic target in germinal center lymphomas. In this study, we assessed the frequency and distribution of EZH2 mutations in a large cohort of patients with follicular lymphoma (FL) (n = 366) and performed a longitudinal analysis of mutation during the disease progression from FL to transformed FL (tFL) (n = 33). Mutations were detected at 3 recurrent mutation hot spots (Y646, A682, and A692) in 27% of FL cases with variant allele frequencies (VAF) ranging from 2% to 61%. By comparing VAF of EZH2 with other mutation targets (CREBBP, MLL2, TNFRSF14, and MEF2B), we were able to distinguish patients harbori…

endocrine systemTime FactorsMethyltransferasemedicine.medical_treatmentDNA Mutational AnalysisImmunologyFollicular lymphomaKaplan-Meier Estimatemacromolecular substancesBiologymedicine.disease_causeBiochemistryTargeted therapyCohort StudiesGene Frequencyhemic and lymphatic diseasesBiomarkers TumormedicineHumansEnhancer of Zeste Homolog 2 ProteinLymphoma FollicularAllele frequencyMutationLymphoid NeoplasiaMEF2 Transcription FactorsGene Expression ProfilingEZH2Polycomb Repressive Complex 2Germinal centerCell BiologyHematologymedicine.diseaseCREB-Binding ProteinLymphomaMutationDisease ProgressionCancer researchReceptors Tumor Necrosis Factor Member 14Blood
researchProduct

Bioassays for TSH Receptor Antibodies: Quo Vadis?

2015

Autoantibodies (Ab) to the TSH receptor (TSHR) are responsible for many of the clinical manifestations of Graves' disease (GD) and are specific biomarkers of this autoimmune thyroid disorder (AITD) [1,2,3]. These Ab can be measured either via competitive-binding immunoassays or with bioassays [4]. Antibody-binding assays only report the presence or absence of TSHR-Ab and their concentrations, but do not indicate their functional activity. Bioassays, in contrast, indicate whether TSHR-Ab have stimulatory or blocking activity [5]. Historically, bioassays for TSHR-Ab were research tools used to study the pathophysiology of GD. Recently, however, there are increasing data that demonstrate the c…

endocrine systemendocrine system diseasesbiologybusiness.industryEndocrinology Diabetes and MetabolismThyroidAutoantibodymedicine.diseaseeye diseasesThyroiditisThyroid disordermedicine.anatomical_structureEditorialImmunologymedicinebiology.proteinBioassayBiomarker (medicine)AntibodyChronic thyroiditisbusiness
researchProduct

Guidelines for biomarker discovery in endometrium: correcting for menstrual cycle bias reveals new genes associated with uterine disorders

2021

Abstract Transcriptomic approaches are increasingly used in reproductive medicine to identify candidate endometrial biomarkers. However, it is known that endometrial progression in the molecular biology of the menstrual cycle is a main factor that could affect the discovery of disorder-related genes. Therefore, the aim of this study was to systematically review current practices for considering the menstrual cycle effect and to demonstrate its bias in the identification of potential biomarkers. From the 35 studies meeting the criteria, 31.43% did not register the menstrual cycle phase. We analysed the menstrual cycle effect in 11 papers (including 12 studies) from Gene Expression Omnibus: t…

endometriosisEmbryologyUterine fibroidsmedia_common.quotation_subjectmenstrual cycle progressionEndometriosisBiologyBioinformaticsEndometriumdifferential expressionEndometriumendometrial pathologiesGeneticsmedicineHumansuterine fibroidsBiomarker discoveryMolecular Biologytranscriptomic analysisMenstrual CycleMenstrual cycleOriginal Researchrecurrent implantation failuremedia_commonUterine Diseasesrecurrent pregnancy lossObstetrics and GynecologyCell Biologymedicine.diseaseAcademicSubjects/MED00905Uterine DisorderMenstrual cycle phaseconfounding variablemedicine.anatomical_structureReproductive Medicinegene expressionOvarian EndometriosisFemaleTranscriptomeDevelopmental BiologyMolecular Human Reproduction
researchProduct

Screening for Low Energy Availability in Male Athletes: Attempted Validation of LEAM-Q

2022

A questionnaire-based screening tool for male athletes at risk of low energy availability (LEA) could facilitate both research and clinical practice. The present options rely on proxies for LEA such screening tools for disordered eating, exercise dependence, or those validated in female athlete populations. in which the female-specific sections are excluded. To overcome these limitations and support progress in understanding LEA in males, centres in Australia, Norway, Denmark, and Sweden collaborated to develop a screening tool (LEAM-Q) based on clinical investigations of elite and sub-elite male athletes from multiple countries and ethnicities, and a variety of endurance and weight-sensiti…

endurancevalidationMaleNutrition and DieteticsquestionnaireReproducibility of ResultsDizzinessSports Nutritional Physiological Phenomenatestosterone; endurance; questionnaire; validation; EHMCEHMCVDP::Medisinske Fag: 700::Helsefag: 800::Ernæring: 811AthletesSurveys and QuestionnairestestosteroneHumansVDP::Medisinske Fag: 700FemaleBiomarkersFood ScienceNutrients; Volume 14; Issue 9; Pages: 1873
researchProduct

Prevalence of relative energy deficiency in sport among well-trained male Norwegian cyclists and long-distance runners

2016

Masteroppgave i idrettsvitenskap - Universitetet i Agder 2016 Introduction Relative Energy Deficiency in Sport (RED-S) links low and reduced energy availability (EA) with negative health and performance consequences, though not well investigated in male endurance athletes. The aim of this study was to investigate the prevalence of RED-S and associated health consequences in well-trained male endurance athletes. Methods Forty-one subjects, cyclists (n=21) and runners (n=20) [age: 40 (31-45) years; BMI: 23.5 (21.4-24.0) kg/m2; body-fat: 14.0% (10.0-16.5%); training volume: 12 (9-16) h/week presented as median + interquartile range] were recruited. Protocol included assessment of bone health, …

energitilgjengelighetmannlige utholdenhetsutøvereenergy availabilitymale endurance athletesutøverhelsehormonal biomarkersME517athlete healthVDP::Social science: 200::Social science in sports: 330::Physical education and sport psychology: 333beinhelsehormonelle biomarkørerbone healthresting metabolic ratehvilemetabolisme
researchProduct

The level of context dependence of engagement markers in Peninsular Spanish and US business websites

2019

This paper examines the impact of Spaniards’ and North-Americans’ level of context dependence (Hall, 1976) on the engagement markers (Hyland & Tse, 2004) used on the presentation page of 100 business websites from the toy sector (50 from Spain and 50 from the US). Following an observational and a quantitative analysis, the findings reveal remarkable statistical differences in the interactional discourse of this digital genre, which may be a valuable source of information for export companies to introduce their products abroad by means of their business websites. In addition, we believe that the business website can be used in the teaching and learning of Spanish and English for professional…

engagement markerslcsh:P101-410business.industrymedia_common.quotation_subjectContext (language use)digital genreGeneral MedicinePublic relationsIntercultural communicationlcsh:Language. Linguistic theory. Comparative grammarcontextFocus (linguistics)Intercultural communicationPresentationQuantitative analysis (finance)Observational studySociologybusinessmedia_commonRevista de Lenguas para Fines Específicos
researchProduct

The interplay between metabolome, epigenome and metabolic syndrome in severe obesity: the influence of sex and age

2022

Antecedentes: la obesidad en adultos se define como una acumulación anormal o excesiva de grasa que representa un importante factor de riesgo para la salud, contribuyendo a aumentar la morbilidad y la mortalidad. Aunque las condiciones de salud subyacentes y la genética podrían ser en algunos casos las principales causas de la obesidad, en la mayoría de los casos es el resultado de estilos de vida poco saludables a largo plazo. En su forma más severa clínicamente (obesidad de Clase III), el tejido adiposo se convierte en el órgano endocrino metabólico más grande que interactúa fuertemente con el sistema endocrino y contribuye al desarrollo del síndrome metabólico (MetS). El MetS es consider…

epigenetic driftUNESCO::CIENCIAS DE LA VIDA::Fisiología humana ::Metabolismo humanometabolomic and methylation profilebiomarkersadipocyte cell culturesex and agehormonal influencemetabolic syndrome
researchProduct